Torrent Pharmaceuticals (TORNTPHARM) — Announcement

Torrent Pharmaceuticals announced the resignation of Executive Director Pranav Mehta effective February 26, 2025, following SEBI Regulation 30 requirements. The filing details his departure and includes resignation documentation, marking a leadership change in strategic planning.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"How does this announcement affect Torrent Pharmaceuticals Limited's outlook?" "What did Torrent Pharmaceuticals Limited announce on 27 February 2025?" "Is this positive or negative for TORNTPHARM?"

Ask AI Free →

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

🔥 Also filed on 27 February 2025

LUPIN Lupin Limited Corporate Action MOTHERSON Samvardhana Motherson International Limited Corporate Action ULTRACEMCO UltraTech Cement Limited Board Meeting BPCL Bharat Petroleum Corporation Limited Voting Results HAL Hindustan Aeronautics Limited Board Meeting

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.